期刊文献+

HPLC-FIA法检测糖基化终末产物方法的建立 被引量:6

Establishment of An Analyzing Approach for Advanced Glycation End Products Formed in Vitro by Flow Injection Assay
下载PDF
导出
摘要 目的:建立糖基化终末产物(advanced glycation end products,AGEs)的一种检测方法。方法:利用高效液相色谱议(high performance liquid chromatography,HPLC)构建流动注射分析系统,检测体外制备的AGEs。荧光检测的激发波长和发射波长(Ex/Em)为370/440 nm。结果:Ex/Em为370/440 nm时,在原反应液的0.1~0.000 1浓度范围内仍有良好的线性,Y=67 979.98X+4.38,r=0.999 99;平均回收率98.5%,RSD= 3.4%。结论:流动注射分析(flow injection assay,FIA)是较可靠的检测AGEs水平的新方法。 Objective: To establish an analyzing approach for advanced glycation end products formed in vitro. Methods: Flow injection system was assembled using HPLC to detect AGEs formed in vitro. Fluorescence of each sample was determined at excitation/emission wavelengths of 370/440 nm. Results: There was a good liner between AGEs concentration (diluted to 0.1-0.000 1) and peak area (obtained at 440 nm with excitation at 370 nm). The equation was y = 67 979.98 x + 4.38, r = 0.999 99. The average recovery rate was 98.5%, RSD = 3.4%. Conclusions: AGEs detected by flow injection assay show excellent accuracy and reproducibility. It is a novel method for monitoring AGEs formed in vitro.
出处 《抗感染药学》 2007年第2期66-68,共3页 Anti-infection Pharmacy
关键词 糖基化终末产物(AGEs) 流动注射分析(FIA) 高效液相色谱仪(HPLC) Advanced glycation end products(AGEs) flow injection assay(FIA) high performance liquid chromatography(HPLC)
  • 相关文献

参考文献3

  • 1[1]A.Ashley Booth,Raja G.Billy G,et al.The journal of biological Chemistry[J].1997,272(9):5430-5437.
  • 2[2]Brownlee M,Vlassara H,Cerami A.Nonenzymatic glucosylation products on collagen covalently trap low-density lipoprotein[J].Diabetes,1985,34(9):938.
  • 3[3]Yoji Hamada,Norie Araki,Naoki Koh,et al.Biochemical and apid formation advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway[J].Biophysical Re-search Communications,228:539-543.

同被引文献61

  • 1魏芹,刘乃丰.羧甲基赖氨酸的研究进展[J].东南大学学报(医学版),2005,24(4):269-273. 被引量:8
  • 2冯建勋,李红艳,田建伟.饮食中晚期糖基化终产物对健康SD大鼠肾脏的影响[J].中国临床康复,2006,10(36):116-119. 被引量:9
  • 3Makita Z, Vlassara H, Cerami A, et al. Immunoehemical detection of advanced glycosylation end products in vivo[J]. J. Biol. Chem, 1992, 267:5133 - 5138.
  • 4Makita Z, Vlassara H, Rayfield E, et al. Hemoglobin - AGE : A circulating marker of advanced glycosylation [ J ]. Science, 1992,258 : 651 - 653.
  • 5Mitsuhashi T,Nakayama H,Itoh T,et al. Immunochemical detection of advanced glycation end products in renal cortex from STZ - induced diabetic rat[ J]. Diabetes, 1993,42:826 - 832.
  • 6Hammes HP, Wellensiek B, Kloting I,et al. The relationship of glycaemic level to advanced glycation end -products accumulation and retinal pathology in the spontaneous diabetic hamster[ J]. Diabetologia, 1998,41:165.
  • 7Mandarino LJ. Current hypotheses for the biochemical basis of diabetic retinopathy[ J ]. Diabetes Care, 1992,15 (12) : 1892 - 1901.
  • 8Krolewski AS, Warfare JH, Valsania P, et al. Evolving natural history of coronary artery disease in diabetes meUitus[ J]. Am. J. Meal,1991, 90:56S -61S.
  • 9Hammes HP, Wellensiek B, Kloting I, et al. The relationship of glycaemic level to advanced glycation end - product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster[ J]. Diabetologia, 1998,41 (2) :165 - 170.
  • 10HWANG I G, KIM H Y, WOOB K S, et al. Biological activities of Maillard reaction products (MRPs) in a sugar-amino acid model system [J]. Food Chemistry, 2011, 126: 221-227.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部